Ceribell, Inc. (CBLL) company profile
Close on Nov 13, 2026Market cap $1.00BP/E –Yield –
About Ceribell
Electromedical & Electrotherapeutic Apparatus, SIC 3845
CeriBell, Inc. is a medical technology company that provides point-of-care electroencephalography (EEG) diagnostic and monitoring solutions for acute care settings. Its primary offering is the Ceribell System, which pairs artificial intelligence algorithms with portable hardware, including disposable headbands, headcaps, and a pocket-sized recorder, alongside a web-based portal for remote data access. Through its Clarity system and monitoring tools, the company serves hospitals, clinicians, and neurologists managing critically ill patients experiencing or at risk of seizures and status epilepticus.
The company operates primarily within the United States acute care market. As of December 31, 2025, more than 600 hospitals have adopted the Ceribell System, ranging from academic medical centers to community facilities. CeriBell maintains principal executive offices in Sunnyvale, California, and relies on an international manufacturing and supply chain network for components and production.
Summary of the business section of Ceribell's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Ceribell, Inc.
- Headquarters
- Sunnyvale, CA
- Address
- 360 N. Pastoria Avenue 94085
- Phone
- (800) 436-0826
- Website
- ceribell.com
- Employees
- 327, Dec 31, 2025
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, San Jose, California
Stock & identifiers
- Ticker
- CBLL
- Exchange
- Nasdaq
- IPO date
- Oct 11, 2024
- Shares outstanding
- 38M, Aug 6, 2026
- Public float
- $417.20M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1861107
- CUSIP
- 15678C102
- ISIN
- US15678C1027
- FIGI
- BBG00KMSVGN4
- Share class FIGI
- BBG00KMSVGP2
- LEI
- 254900XFP5492GQXKO05
- EIN
- 47-1785452
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Xingjuan Chao | President and CEO, Director | 1,115,433 |
| Raymond Woo | Chief Technology Officer | 203,118 |
| Scott Blumberg | Chief Financial Officer | 147,446 |
| David Foehr | Senior VP, Finance and PAO | 34,144 |
| Joseph S. Manni | Chief Revenue Officer | 55,956 |
| William W. Burke | Director | 23,022 |
| Joseph Michael Taylor | Director | 38,278 |
| Sharon O'Keefe | Director | 16,011 |
| Thomas A. West | Director | 16,011 |
| Josef Parvizi | Director | 2,007,489 |
| Rebecca B. Robertson | Director | 26,587 |
| Bakker Juliet Tammenoms | Director | 2,498,394 |
| Erica J. Rogers | Director | 33,054 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Xingjuan (Jane) Chao President, Chief Executive Officer, and Co-Founder | $639.00K | $1.71M | $1.57M | $619.31K | $26.20K | $4.57M | +151% |
| Scott Blumberg Chief Financial Officer | $430.00K | $576.15K | $531.29K | $247.07K | – | $1.78M | +76% |
| Raymond Woo Chief Technology Officer | $418.50K | $576.15K | $531.29K | $238.59K | – | $1.76M | +151% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Oct 11, 2024
- Offer price
- $17.00
- Securities offered
- 10,606,060
- Gross proceeds
- $180.30M
- Exchange
- Nasdaq
- First trading day
- Oct 11, 2024
- First-day close
- $25.00+47.1%
- Lock-up ends (est.)
- Apr 9, 2025
“The public offering price is $17.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 327 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 11, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 8, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?